Hepatitis-B surface antigen and cirrhosis in Iraq.

Boxall, E H; Flewett, T. H.; Paton, Alex; Rassam, Suha

doi:10.1136/gut.17.2.119

Cited by 11 publications

(3 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In London at a specialist centre 58% of 65 cases of cirrhosis had HBsAg in the serum (Portmann et al, 1976), in Belgium 49% of 41 cases (van Waes et al, 1974), and in Iraq 58 % of 64 cases (Boxall et al, 1976). In London HBsAg was identified in the serum of0-3 % of 1489 control hospital patients by the relatively insensitive immunodiffusion method (Medical Research Council, 1974).…”

Section: Discussionmentioning

confidence: 99%

Aetiology of cirrhosis, hepatic fibrosis, and hepatocellular carcinoma.

Blenkinsopp¹,

Haffenden²

1977

J Clin Pathol

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Aetiology of cirrhosis, hepatic fibrosis, and hepatocellular carcinoma.

Blenkinsopp¹,

Haffenden²

1977

J Clin Pathol

View full text Add to dashboard Cite

“…High incidence of HBsAg sero positivity in the patients with CLD ranging from 25 to 60% had been reported from Iraq [21], Greece [22], Africa [23] and India [24]. All of these countries have high HBsAg seroprevalence amongst the general population [22][24].…”

Section: Discussionmentioning

confidence: 99%

Association of haematological and biochemical parameters, ultrasonographic and upper GI endoscopic findings with sero prevalence of HBV and HCV among chronic liver disease patients in a tertiary care hospital

Gomes¹

2020

G Med Sci

View full text Add to dashboard Cite

Background: Now-a-days chronic liver disease is one of the major health problems in the world. In developing countries, chronic liver disease due to hepatitis virus (like hepatitis B and hepatitis C virus) is increasing day by day. It is rapidly emerging as a major health problem. So, the present study was conducted to document the hepatitis B and hepatitis C virus in patient with chronic liver disease by an easy and simple marker like HBsAg, Anti HBc (total) and Anti HCV in a tertiary hospital. Methods: Serum samples were collected from 100 selected cases who were diagnosed as a case of chronic liver disease in medicine and gastroenterology department of DMCH. Study period was from April 01, 2016 to September 30, 2018. For detection of HBsAg, Anti HBc (total) and Anti-HCV, Immunochromatographic test (ICT) was done in every case. Results: Out of 100 cases, HBsAg seropositive with negative Anti-HCV was found in 64% cases, Anti HCV positive with negative HBsAg was found in 16% cases, both HBsAg and Anti HCV positive was found in 4% cases, both HBsAg and Anti-HCV negative was found in 16% cases. Among these cases, 74% were male and 26% were female. Here male: female was 3:1 and among them, 75% male was seropositive for either HBsAg or Anti-HCV. Conclusion: The high frequency of seropositivity in patients with chronic liver disease with male predominance is found in tertiary care settings. The number of Anti-HCV seropositive patient indicates that it is an emerging health problem in our country.

show abstract

“…High incidence of HBsAg seropositiviry in the patients with CLD ranging from 25 to 60% had been reported from Iraq [21], greece [22], Africa [23] &India [24]. All of these countries have high HBsAg seroprevalence amongst the general population [22,24].…”

Section: Methodsmentioning

confidence: 99%

Evaluation of association of demographic profiles and sero prevalence of HBV and HCV among the patients presenting with chronic liver disease and its complications: A Tertiary Care Hospital Based Study

Gomes¹,

Ali²

2020

Open J Hepatol

View full text Add to dashboard Cite

Chronic liver disease is one of the common hepatobiliary problems worldwide. A major portion of the cases of chronic liver disease presents as a sequel of hepatotrophic viral infection specially hepatitis B and hepatitis C virus. Hepatitis B virus infects more than 350 million people worldwide and it is a leading cause of chronic hepatitis, cirrhosis and hepatocellular carcinoma [1]. On the other hand hepatitis C virus infects an estimated 170 million people worldwide and it represents a viral pandemic and mostly causes chronic infection leading to cirrhosis in 15-20% of those [2]. In Bangladesh the prevalence of chronic viral hepatitis [3,4] is quite signifi cant. It has been observed that a large number of people in Bangladesh suffer

show abstract

Hepatitis-B surface antigen and cirrhosis in Iraq.

Cited by 11 publications

References 9 publications

Aetiology of cirrhosis, hepatic fibrosis, and hepatocellular carcinoma.

Aetiology of cirrhosis, hepatic fibrosis, and hepatocellular carcinoma.

Association of haematological and biochemical parameters, ultrasonographic and upper GI endoscopic findings with sero prevalence of HBV and HCV among chronic liver disease patients in a tertiary care hospital

Evaluation of association of demographic profiles and sero prevalence of HBV and HCV among the patients presenting with chronic liver disease and its complications: A Tertiary Care Hospital Based Study

Contact Info

Product

Resources

About